Search Results (971)

Background: Bee-derived products are rich in bioactive compounds with antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory properties. Interest is growing in their potential role as adjuncts in supportive nutritional oncology, particularly for preventing and managing treatment-related toxicity symptoms in patients receiving chemotherapy and/or radiotherapy. Methods: A systematic search of human and preclinical studies was conducted in PubMed/MEDLINE, Web of Science, and Scopus from January 2000 to December 2025. Search terms combined bee-related product keywords with oncology-related keywords. Eligible studies included in vitro and in vivo preclinical models as well as clinical studies assessing biological properties, clinical outcomes, safety, and issues of product standardization. Results: Preclinical and clinical studies indicate that beehive products reduce oxidative stress, modulate inflammatory signaling pathways, exhibit antimicrobial activity against wound pathogens, and promote tissue repair. Results are most consistent for oral mucositis and for symptom management in head and neck cancer, where some studies report reduced pain, improved mucosal healing, and better nutritional status. Conclusions: This literature review identifies honey and beehive products as promising functional foods for improving oncological patient care. Further large studies are needed, as the evidence is heterogeneous across sample size, product composition, outcome measures, and therapeutic preparations. Full article

Laser acupuncture (LA) integrates principles of traditional acupuncture with photobiomodulation (PBM) and has gained increasing attention as a non-invasive modality for pain management. PBM-based integrative LA in medicine refers to the application of low-level laser irradiation to acupuncture points, combining contemporary biomedical mechanisms with holistic, system-oriented therapeutic principles. This narrative review aimed to critically assess the scientific evidence on the efficacy of LA for pain management within the framework of the Principles of Clinical Integration of Photobiomodulation (PCIPBM) in LA, summarizing frequently used laser parameters and clinical indications. LA involves special protocols in standardized acupoints, using defined parameters of wavelength, irradiation, and energy density, consistent with PBM dosing principles. Therapeutic effects are mediated through point-specific neuromodulation and photobiological mechanisms, including modulation of peripheral and central nociceptive processing, reduction in pro-inflammatory mediators, improvement of microcirculation, and mitochondrial activation via cytochrome c oxidase-dependent adenosine triphosphate (ATP) synthesis. Clinical studies report statistically and clinically significant analgesic effects, particularly in chronic musculoskeletal pain, osteoarthritis, low back and neck pain, temporomandibular disorders, neuropathic pain, and selected postoperative pain conditions, when appropriate laser parameters are applied. Reported adverse effects are minimal, and tolerability is high. LA represents a safe, non-invasive therapeutic option and patient-friendly approach with clinically relevant efficacy in pain management. When applied according to PCIPBM, including evidence-based PBM parameters, it may serve as an effective adjunct or alternative to conventional pharmacologic and interventional approaches. Further standardization and high-quality randomized controlled trials are still required. Full article

Chronic pain is increasingly understood as a neuroimmune disorder rather than a purely neuronal condition, in which immune mediators and immune-like signaling within the nervous system regulate nociceptive gain across peripheral tissues, dorsal root ganglia (DRG), spinal cord, and supraspinal networks. Seminal and recent syntheses show that microglia, macrophages, cytokines/chemokines, and innate immune sensors can initiate and maintain maladaptive plasticity and central sensitization, helping explain the frequent clinical dissociation between structural pathology, systemic inflammatory markers, and pain severity. However, immune biology is bidirectional: alongside pronociceptive pathways, a growing literature describes active “pain-resolving” programs that terminate sensitization and restore homeostasis, including regulatory T cell (Treg)–IL-10 signaling and specialized pro-resolving mediators (SPMs). A structured search of PubMed/MEDLINE, supplemented by Europe PMC and PubMed Central, was performed, and citation chasing through broad scholarly indices was used to identify high-impact reviews, meta-analyses, and translational mechanistic studies. Systematic biomarker syntheses in low back pain, neck pain, and fibromyalgia indicate modest and heterogeneous systemic inflammatory signals, underscoring the need for mechanistic endotyping and stage-specific interventions. Based on this evidence, a clinically oriented framework is presented that distinguishes immune-driven pain amplification from impaired resolution and outlines practical implications for assessment, biomarker interpretation, and precision-oriented trial design. Full article

Background/Objectives: Non-specific chronic neck pain is one of the biggest problems in the current population, with high levels of pain and disability and a decrease in the quality of life. The aim of this study is to assess possible variables that may be associated with neck pain, such as disability, pain, quality of life, sex, neck muscle endurance, active range of motion (AROM) and frequency of drug use. Methods: We performed a cross-sectional study of non-specific chronic neck pain with a total of 105 subjects. The variables pain-related disability, pain, quality of life, sex, AROM and frequency of drug use were evaluated. Results: A total of 105 patients with chronic neck pain were included (mean age 40.47 ± 12.18 years; 67.6% women). Neck pain–related disability showed significant negative correlations with all cervical AROM variables, particularly left rotation (r = −0.507) and right rotation (r = −0.489) (p < 0.001). Disability was also negatively correlated with health-related quality of life (r = −0.604) and positively correlated with pain intensity (r = 0.414) and frequency of drug consumption (r = 0.546) (p < 0.001). Regression analyses indicated that disability was associated with reduced left rotation mobility and higher drug consumption (R² = 0.424). Pain intensity was associated with female sex, reduced right rotation mobility, and higher drug consumption (R² = 0.246). Lower health-related quality of life was associated with higher drug consumption and female sex (R² = 0.174). Conclusions: Being female, having a reduction in active rotational mobility, and a high frequency of drug consumption are associated with greater pain-related disability and pain intensity, and a lower HRQoL in subjects with non-specific chronic neck pain. Full article

Patients with head and neck cancer (HNC) face a high risk of malnutrition and sarcopenia, often exacerbated by the toxicities of chemoradiotherapy, such as dysphagia, xerostomia, and mucositis. These Nutritional Impact Symptoms significantly compromise oral intake and negatively affect quality of life. This paper presents a conceptual framework designed to support clinicians in optimizing oral intake through personalized nutritional management. Central to this approach is the integration of systematic screening using MUST, the Malnutrition Universal Screening Tool (MUST), and the Nutritional Risk Screening 2002 (NRS-2002). Furthermore, functional assessment of swallowing via instrumental studies (VFSS/FEES) is essential for tailoring dietary textures according to the International Dysphagia Diet Standardization Initiative framework. Key nutritional strategies include high-energy and high-protein oral fortification, the use of oral nutritional supplements, and specific dietary adjustments addressing pain management and sensory alterations. A multidisciplinary approach involving nutritionists, speech-language pathologists, and oncologists is paramount to transition from reactive symptom management to proactive “adaptive nutrition,” ultimately improving clinical outcomes and patient survival. Full article

Chronic neck pain (CNP) is associated with pain-related neuromuscular adaptations; however, in contrast to other superficial neck muscles, the influences of pain on hyoid muscles remain to be investigated. This study investigated how hyoid and superficial neck muscle activity differ between individuals with and without CNP during dynamic neck flexion and extension. In this observational cross-sectional, case–control study, 20 individuals with CNP and 20 sex- and age-matched asymptomatic controls were recruited. All participants performed dynamic neck flexion and extension in a crook-lying position at a controlled tempo. Surface electromyography was used to examine bilateral sternocleidomastoid (SCM), anterior scalene, upper trapezius, suprahyoid, and infrahyoid muscle activity. Normalised EMG values and their absolute phase-to-phase changes were analysed using linear mixed-effects models. A significant group × muscle interaction was observed (F = 3.34, p < 0.001, η² = 0.04), with higher normalised EMG values in the bilateral anterior scalene (left: GMR = 1.42, p = 0.01; right: GMR = 1.37, p = 0.03) and suprahyoid muscles (left: GMR = 1.42, p = 0.01; right: GMR = 1.37, p = 0.03) in individuals with CNP. In contrast, the phase-to-phase changes did not differ between the groups. These findings suggest that individuals with CNP exhibit selective alterations in muscle activation patterns. Full article

Background: Extracranial metastasis (EM) from glioblastoma (GB), IDH-wildtype (WHO CNS 2021 grade 4) is rare and often under-recognized, yet it has immediate implications for staging and management. We report a case series integrating advanced neuroimaging, whole-body imaging, and pathology/biomarkers to characterize imaging–pathology correlates of EM and highlight practical clinical triggers that should prompt systemic evaluation. Case presentation: We report three patients with adult-type, IDH-wildtype GB who developed EM confirmed by cytology/histology and/or concordant multimodality imaging. Brain MRI (1.5T/3T) demonstrated aggressive primary tumors with qualitative elevation of DSC-perfusion and frequent tumor–surface contact (dural, ependymal/leptomeningeal contact). Intratumoral susceptibility signal reached grade 3 where assessed. All patients underwent surgical resection followed by temozolomide-based chemoradiation; two received fotemustine and bevacizumab, and one underwent re-irradiation. EM presented with clinical triggers including severe axial/back pain, palpable cervical masses, and/or cytopenias. Initial EM sites were bone marrow/vertebrae (n = 1) and cervical lymph nodes (n = 2); staging revealed additional osseous disease in both nodal cases and a small pulmonary nodule in one. Nodal and osseous lesions were FDG-avid on 18F-FDG PET/CT. OLIG2-positive cytology confirmed cervical nodal metastases, and bone marrow aspiration with GFAP/OLIG2 positivity confirmed medullary infiltration. All tumors shared a molecular profile of TERT-promoter mutation, ATRX wild-type, TP53 mutation, and MGMT-promoter methylation. Despite attempts at second- and third-line therapies, disease progression was rapid, and all patients succumbed within 8–16 months of diagnosis. Discussion: This series underscores that EM can occur despite MGMT-promoter methylation and supports the concept of heterogeneous metastatic phenotypes in GB. Our cases reinforce that new axial/back pain or hematologic abnormalities may signal osseous or marrow involvement, and necrotic cervical lymphadenopathy in GB patients warrants dedicated imaging and tissue confirmation with glial markers. Integrating brain MRI features (high perfusion, surface contact, susceptibility burden) with FDG-PET/CT and targeted cytology/pathology can expedite diagnosis and inform multidisciplinary care. Conclusions: EM can arise despite MGMT-promoter methylation in IDH-wildtype GBM. Imaging red flags (high perfusion, surface contact, necrotic/FDG-avid cervical nodes) and clinical cues (axial pain, cytopenias, neck masses) should prompt early systemic staging (CT/PET-CT) and targeted tissue confirmation to advance management. Full article

Background: We report a rare case of a metastatic neoplasm in the regional lymph nodes and peritoneum whose histopathologic and immunophenotypic profiles were most consistent with a diagnosis of medullary thyroid carcinoma (MTC), although a primary tumor was not histologically demonstrated in the thyroidectomy specimen. Case presentation: A 64-year-old man presented with abdominal pain and was found to have increased calcitonin level and a 20 mm lesion in the peritoneum. Peritoneum biopsy revealed plasmacytoid tumor cells which were positive for calcitonin and synaptophysin staining. The patient had a past history of neck dissection due to left side neck mass. The histology revealed metastatic carcinoma with a nested pattern surrounded by fibrous stroma with stromal amyloid deposition. With immunohistochemistry, the findings were most consistent with metastatic MTC, but following total thyroidectomy showed no malignancy. Next-generation sequencing identified a pathogenic HRAS mutation, but RET mutation was not identified. Despite vandetanib treatment, the disease progressed and the patient expired. Conclusions: This case highlights a rare presentation of a metastatic neoplasm highly suggestive of RET wild-type MTC with peritoneal involvement, despite the absence of an identifiable primary lesion. Full article

Background: Musculoskeletal pain affects an estimated 1.7 billion people worldwide and ranks among the leading causes of global disability. This review evaluates the effectiveness and safety of osteopathy in treating musculoskeletal pain across multiple body regions and conditions. Methods: A systematic literature review following PRISMA guidelines was conducted across five databases (Embase, Medline via Ovid, The Cochrane Library, PEDro, and INAHTA), yielding 964 citations. Eligible studies were RCTs published in English or German up to May 2022; conference abstracts were excluded. A hybrid design was employed: a systematic review of RCTs for neck, shoulder, knee, foot, osteoporosis, and fibromyalgia was combined with a pre-specified umbrella review component for chronic non-specific low back pain (registered in PROSPERO) to avoid duplication of an existing high-confidence evidence synthesis. From 35 critically appraised articles, the best available evidence (n = 15) was selected per body region based on a risk of bias (RoB) assessment (Cochrane Collaboration tool, version 1); the existing review was appraised with AMSTAR 2. An updated search (2022–July 2025) was performed without a RoB assessment. Data were synthesised qualitatively and reported narratively. Results: Fifteen RCTs and one systematic review were included, covering eight body regions and conditions (2408 participants). Pain improved immediately post-treatment in most regions; statistically significant between-group differences were less consistent at mid- and long-term follow-ups. Key findings: neck pain (n = four RCTs)—improvement in three of four studies immediately post-treatment; shoulder pain (n = two RCTs)—improvements across all follow-up points in one study; low back pain (n = one systematic review, 10 RCTs, 1160 participants)—pain reduced immediately and at mid-term follow-up; knee pain (n = two RCTs)—significant reduction in one study; foot pain (n = two RCTs)—improvement in both studies post-treatment and at mid-term follow-up; osteoporosis (n = one RCT)—no improvement immediately post-treatment; fibromyalgia (n = two RCTs)—significant between-group differences in one study post-treatment and at mid-term follow-up. Functional outcomes were heterogeneous across regions. Adverse events were minor and transient; no serious side effects were reported across any included study. The updated search (2022–July 2025) identified 12 additional RCTs across five regions, with findings broadly consistent with the primary analysis, though results for the neck region were marginally less favourable. Discussion: Based on current evidence, osteopathy can improve neck and low back pain for up to three months and may reduce shoulder and foot pain; evidence for other body regions remains inconclusive. RoB was unclear to high across studies, largely due to the inherent inability to blind patients and practitioners in manual therapy trials. Substantial heterogeneity in interventions, outcome measures, and study designs limits comparability. Overall certainty of evidence was low to moderate, warranting cautious interpretation. The consistent absence of serious adverse events across all included studies supports osteopathy as a safe therapeutic option. High-quality research with standardised interventions, rigorous designs, long-term follow-ups, and a focus on technique, dosage, and safety is needed to inform clinical practice and healthcare policy. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sector. Full article

The objective of this study was to evaluate, in client-owned dogs, the postoperative analgesic efficacy of the centrally acting analgesic tramadol following femoral head and neck excision (FHNE). Thirty-eight dogs were diagnosed with coxofemoral disease and underwent FHNE. The sample was randomly divided into two groups. Postoperatively, dogs in Group A received robenacoxib (2 mg kg⁻¹ bodyweight, sid, per os) until they achieved final weight-bearing of the operated limb, whereas dogs in Group B received the same regimen of robenacoxib in combination with tramadol (5 mg kg⁻¹ bodyweight, tid, per os) for fifteen days. All animals were premedicated, sedated, and anesthetized following the same standardized protocol to ensure consistency between groups. Postoperative evaluations were conducted on days 15 and 30, and subsequently at monthly intervals, until full weight-bearing of the affected limb was achieved. Clinical assessments included observation of pain-related behaviors, lameness scoring, and time to initial weight-bearing (TIWB) and time to final weight-bearing (TFWB). Data normality was assessed using the Shapiro–Wilk test, and differences between groups were evaluated using the independent samples T-test (p = 0.05). Statistical analysis revealed no significant differences between the two groups regarding time to initial (p = 0.087) or final weight-bearing. However, a moderate effect size (d = 0.570) was observed for TIWB, suggesting a clinically interesting trend toward faster early recovery in the multimodal group. These findings indicate that while adding tramadol did not confer a statistically significant additional advantage in this study, the observed clinical trend warrants further investigation in larger, higher-powered cohorts to determine its definitive clinical impact. Full article

Background: Symptom scales are routinely used in sport during concussion screening and return-to-play. Limited research has explored the presence of concussion symptoms in the absence of a diagnosed concussion. This study analyzed concussion symptom scores in concussed vs. non-concussed football players after football activities and evaluated the effect of field of play variables. Methods: NCAA Division I football players with (n = 9) and without (n = 30) diagnosed concussion completed concussion symptom scales (C3 Logix) following practice for 1 week. Wet bulb globe temperature (WBGT), play duration, equipment, and location (inside/outside) were recorded. Mixed models analyzed the effect of day, WBGT, equipment, location, and play duration on concussion-like symptoms in non-concussed players and determined the time course of symptom relief in concussed players. Results: Fatigue or low energy (27.6%), neck pain (16.8%), feeling slowed down (14.8%), and headache (12.8%) were most reported. In non-concussed players, total symptoms scores were higher early in the week (Monday/Tuesday) and decreased throughout the week (p < 0.01). No effect of play duration (p = 0.49), WBGT (p = 0.12), equipment (p = 0.40), or location (p = 0.83) was found. Symptom scores were greater in the concussed vs. non-concussed groups on days 1–3. Conclusions: Football players report concussion-like symptoms in the absence of a concussion diagnosis, particularly following the first few practices after a game. Full article

Background/Objective: Dizziness is managed using various therapies, including lifestyle changes, nutritional supplementation, pharmaceutical therapies, and physical therapy, each offering differing efficacy. With legalization of cannabis in Canada, patients are exploring its use in treating their dizziness and related symptoms. Limited knowledge exists regarding usage patterns, forms, doses, and effects on these symptoms. The current study aims to examine cannabis use in patients experiencing dizziness. Methods: We conducted a cross-sectional study at the Ottawa Hospital outpatient neuro-otology clinic. Eligible participants included new patients presenting with a primary complaint of dizziness and follow-up patients reporting new-onset dizziness. Participants completed a questionnaire capturing demographic data, dizziness and related symptoms, attitudes toward cannabis use, consumption patterns, and its perceived effects on their symptoms. Results: Of 154 participants, 118 (77%) expressed willingness to consider cannabis for dizziness and 78 (51%) reported previous cannabis use. Of those patients, 44 (56%) consumed it recreationally, largely via smoking (29/78, 37%). Approximately 21% of these patients reported a moderate–large subjective relief from dizziness after use of cannabis. The most common diagnoses amongst cannabis users were migraine/vestibular migraine (24%), persistent postural perceptive dizziness (22%), and benign paroxysmal positional vertigo (17%). Other related symptoms relieved by cannabis included sleep (28/78, 36%), emotional difficulties (17/78, 22%), neck pain/stiffness (14/78, 18%) and headaches/migraines (9/78, 12%). Conclusions: There is generally a positive attitude towards cannabis use in treating dizziness amongst patients, with a subset of patients reporting a subjective improvement of dizziness and its related symptoms, such as sleep and emotional difficulties. Full article

Background and Clinical Significance: Immunoglobulin G4-related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory disorder that can mimic infection or malignancy. Spinal involvement is exceedingly rare and usually limited to pachymeningitis or epidural pseudotumors. True vertebral bone destruction has been reported only sporadically. Case Presentation: A 54-year-old man presented to our emergency department with severe neck pain after a fall. CT and MRI revealed extensive osteolysis of the C1 posterior arch and odontoid process with atlantoaxial subluxation. Following a second inpatient fall, he developed acute tetraparesis. Emergency posterior occipitocervical fusion (C0–C4) with C1–C2 laminectomy and foramen magnum decompression was performed. Histopathology demonstrated dense lymphoplasmacytic infiltration and fibrosis with up to 36 IgG4⁺ plasma cells per high-power field and an IgG4⁺/IgG ratio > 40%, confirming IgG4-RD. The patient recovered substantial motor function postoperatively and regained independent ambulation after neurological rehabilitation. Conclusions: IgG4-RD can rarely present as destructive craniovertebral osteolysis with neurological compromise. Unexplained C1–C2 osteolytic lesions should prompt evaluation for IgG4-RD, a rare but treatable cause of cervical instability. Full article

Background: The aim of this study was to derive and internally validate a prescriptive clinical prediction rule (CPR) for identifying baseline factors associated with short-term clinical improvement in patients with neck pain (NP) undergoing a manual therapy (MT)-based physiotherapy program. Methods: A prospective cohort study was conducted, including 71 patients with NP (18–65 years). Participants received six MT-based sessions over three weeks. Baseline assessments included Pain Intensity Numeric Rating Scale (PI-NRS), Neck Disability Index (NDI), Body Mass (BM), Body Mass Index (BMI), International Physical Activity Questionnaire-Short Form (IPAQ-SF), Hospital Anxiety and Depression Scale (HADS), Minnesota Satisfaction Questionnaire-Short Form (MSQ), and Craniovertebral Angle (CVA). Clinical improvement was defined using the Global Perceived Effect Scale (GPES-7). Univariate analyses, receiver operating characteristic (ROC) curve analysis, and forward stepwise logistic regression were performed to derive the predictive model. Results: Fifty-six participants (78.9%) reported moderate to complete improvement. BM ≥ 76.5 kg and MSQ score ≤ 42.5 were retained in the final regression model. When both predictors were present, the probability of clinical improvement increased to 96.43% (positive likelihood ratio = 7.58). The model demonstrated adequate fit (Nagelkerke R² = 0.247; Hosmer–Lemeshow p = 0.804). Internal validation yielded an optimism-corrected AUC of 0.741, suggesting minimal overfitting. Conclusions: Higher BM and lower MSQ score were associated with greater short-term improvement following MT in patients with NP. These findings highlight the relevance of integrating physical and psychosocial factors in prescriptive rehabilitation approaches. External validation of this CPR is required before clinical implementation. Full article

Background: Mitragynine pseudoindoxyl (MP) is a semi-synthetic kratom metabolite increasingly sold online and over-the-counter, marketed misleadingly as “kratom” or “7-OH,” despite lacking FDA approval and safety data in humans. Methods: This case report describes a 44-year-old male with polysubstance use history who developed opioid withdrawal symptoms after regular MP use (400 mg daily for pain management following neck injury). Vital signs, alcohol and opioid withdrawal scores and clinical outcomes were recorded. Results: The patient presented exhibiting symptoms of moderate opioid withdrawal in the absence of other opioid use. A buprenorphine macro-induction protocol was initiated. Following pre-treatment using chlorpromazine as an anti-emetic and diazepam to treat concomitant alcohol withdrawal, 32 mg buprenorphine were provided (16 mg × 2) on day one, with subsequent maintenance dosing and adjunctive medications. The patient demonstrated significant symptomatic improvement with decreased COWS scores and expressed interest in long-acting injectable buprenorphine maintenance therapy. Discussion: This represents the first documented case of suspected MP withdrawal successfully managed with buprenorphine macro-induction, demonstrating the potential efficacy of this approach for novel semi-synthetic kratom metabolites when standard withdrawal management protocols are insufficient. Further studies should evaluate long term outcomes and validate findings. Full article